Windtree Therapeutics

Contributing Author

Recent Articles by Windtree Therapeutics

Jul-02	Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure WINT GlobeNewswire
Jun-30	Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis WINT GlobeNewswire
Jun-26	Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel WINT GlobeNewswire
Jun-16	Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study WINT GlobeNewswire
Jun-11	Windtree Receives Offer for Its Preclinical Oncology Drug Candidate WINT GlobeNewswire
Jun-10	Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business WINT GlobeNewswire
Jun-03	Windtree Announces Plan for Cryptocurrency Treasury Policy WINT GlobeNewswire
May-22	Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025 WINT GlobeNewswire
May-19	Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference WINT GlobeNewswire
May-16	Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates WINT GlobeNewswire
May-12	Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025 WINT GlobeNewswire
May-06	Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US WINT GlobeNewswire
May-01	Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development WINT GlobeNewswire